… we aimed to investigate the efficacy and safety of ICI … Lung cancer is the most common
cancer worldwide, with 1.8 million new cases reported in 2012. The poor prognosis of lung cancer …

Background Postoperative adjuvant cisplatin-based chemotherapy had been the standard
care in patients with completely resected high-risk stage IB to IIIA non-small cell lung cancer (…

… Non-small cell lung cancer (NSCLC) is one of the leading causes of deaths from cancer
worldwide [1]. When used as first-line therapy, first-generation epidermal growth factor receptor (…

… in effectiveness and safety on patients with advanced non-small-cell lung cancer as first-line …
However, the differences in efficacy and safety between docetaxel and pemetrexed are not …

Background To assess the efficacy, safety, tolerability and pharmacokinetics of BIBF 1120 in
patients with stage IIIB/IV non-small-cell lung cancer (NSCLC). Methods Patients with …

Purpose: The objective of this study was to evaluate the efficacy and safety of two doses of
pemetrexed supplemented with folic acid and vitamin B 12 in pretreated Japanese patients …

… The most frequent subtype (87 %) is non-small cell lung cancer (… Aim of the review To
evaluate the efficacy and safety of … Then we extracted data on efficacy and safety according to …

… Lung cancer remains the leading cause of cancer-related morbidity and mortality worldwide
1 . Non-small-cell lung cancer (… as having advanced or metastatic lung cancer at the time of …

… Worldwide, lung cancer is still the leading cause of death, … diagnosed with non-small-cell
lung cancer (NSCLC), with the … was studied by the efficacy and safety of monotherapy versus …

Objectives: Patients receiving induction therapy may have increased risk of morbidity and
mortality after surgery. We retrospectively evaluated the influence of preoperative treatment in …